- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07945704
GLP-1 RAs and Dietary Intake and Body Composition
Longitudinal Effects of GLP-1 Receptor Agonists on Dietary Intake and Body Composition
To assess longitudinal changes in dietary intake, body composition and metabolism with GLP-1 RA use.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiesteder
-
-
Ohio
-
Athens, Ohio, Forente stater, 45701
- Rekruttering
- Exercise Physiology Lab
-
Ta kontakt med:
- Angela Hillman, PhD
- Telefonnummer: 740-593-0153
- E-post: hillman@ohio.edu
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
People taking GLP-1 RA medications
Beskrivelse
Inclusion Criteria:
- Currently taking GLP-1 medications and have been taking them for less than a month
- between the ages of 18-75 years
Exclusion Criteria:
- Not between the ages of 18-75 years
- Not currently using GLP-1 medications
- Have been using GLP-1 medications for 1 month or longer
- Currently pregnant
- Currently nursing
- Bariatric surgery in the last 3 months
- Have an implanted cardiac device, such as a pacemaker or defibrillator
- Not willing to have a DEXA (full body x-ray) at the start and end of the 12 week study period
- Not willing to have a bioelectrical impedance body composition scan at the start and every 2 weeks during the 12 week study period
- Not willing to have your resting metabolism measured at the start and end of the 12 week study period
- Not willing to track your diet at the beginning and end of the study
- Not willing to complete surveys assessing depression, food noise and disordered eating
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
change in body mass
Tidsramme: 12 weeks
|
change in body weight measured in kg using BIA and DEXA |
12 weeks
|
|
change in skeletal muscle mass
Tidsramme: 12 weeks
|
change in skeletal muscle mass measured in kg using BIA and DEXA |
12 weeks
|
|
change in body fat mass
Tidsramme: 12 weeks
|
change in body fat mass measured in kg using BIA and DEXA |
12 weeks
|
|
change in resting metabolism
Tidsramme: 12 weeks
|
change in resting metabolic rate in kcals/day as measured via indirect calorimetry |
12 weeks
|
|
change in substrate utilization rates
Tidsramme: 12 weeks
|
change in resting carbohydrate and fat oxidation rates as measured via indirect calorimetry |
12 weeks
|
|
change in bone mineral content
Tidsramme: 12 weeks
|
change in bone mineral content measured via DEXA and BIA |
12 weeks
|
|
change in bone mineral density
Tidsramme: 12 weeks
|
change in bone mineral density measured via DEXA |
12 weeks
|
|
change in total daily caloric intake
Tidsramme: 12 weeks
|
change in total daily caloric intake measured via 24 hour food diary |
12 weeks
|
|
change in daily carbohydrate intake
Tidsramme: 12 weeks
|
change in daily carbohydrate intake measured via 24 hour food diary |
12 weeks
|
|
change in daily fat intake
Tidsramme: 12 weeks
|
change in daily fat intake measured via 24 hour food diary |
12 weeks
|
|
change in daily protein intake
Tidsramme: 12 weeks
|
change in daily protein intake measured via 24 hour food diary |
12 weeks
|
|
change in daily mineral intake
Tidsramme: 12 weeks
|
change in daily mineral intake measured via 24 hour food diary |
12 weeks
|
|
change in daily vitamin intake
Tidsramme: 12 weeks
|
change in daily vitamin intake measured via 24 hour food diary |
12 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- IRB-FY26-568
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .